Live and recent posts from across the Fediverse tagged #oncologydrugs, aggregated by home.social.
AstraZeneca Gets FDA Priority Review for IMFINZI Combo
AstraZeneca received U.S. FDA Priority Review for IMFINZI plus enfortumab vedotin as a potential treatment for certain muscle-invasive…
#EuropeSays #Britain #Europe #EU #AstraZeneca #AZNstock #bladdercancertreatment #CancerResearch #durvalumab #enfortumabvedotin #FDAPriorityReview #Imfinzi #immunotherapy #nasdaq-azn #OncologyDrugs #pharmaceuticalstocks #VOLGAtrial
https://www.europesays.com/britain/131497/
https://www.europesays.com/britain/131497/ AstraZeneca Gets FDA Priority Review for IMFINZI Combo #AstraZeneca #AZNStock #BladderCancerTreatment #CancerResearch #durvalumab #EnfortumabVedotin #FDAPriorityReview #Imfinzi #immunotherapy #NasdaqAzn #OncologyDrugs #PharmaceuticalStocks #VOLGATrial
AstraZeneca acquires ZEGFROVY rights for $600 million
AstraZeneca completed an exclusive license agreement with Dizal Pharmaceutical for global ZEGFROVY rights.The deal includes a $600 million…
#EuropeSays #Britain #Europe #EU #AstraZeneca #AZNstock #DizalPharmaceutical #EGFRinhibitor #lungcancertreatment #nsclc #OncologyDrugs #pharmaceuticallicensing #Sunvozertinib #Zegfrovy
https://www.europesays.com/britain/115176/
https://www.europesays.com/britain/115176/ AstraZeneca acquires ZEGFROVY rights for $600 million #AstraZeneca #AZNStock #DizalPharmaceutical #EGFRInhibitor #LungCancerTreatment #nsclc #OncologyDrugs #PharmaceuticalLicensing #Sunvozertinib #Zegfrovy
https://www.europesays.com/britain/79975/ Southeast Asia Oncology Drug Access Market Now Available; Profiles Roche, AstraZeneca, Merck, and Other Key Peers #Access #AccessMarket #AstraZeneca #MarketGrowth #MarketInsights #MarketSegmentation #OncologyDrug #OncologyDrugs #PatientAccess #PharmaceuticalCompanies #PrecisionMedicine #SoutheastAsia #StrategicInsights
https://www.europesays.com/ch/100628/ Southeast Asia Oncology Drug Access Market Now Available; Profiles Roche, AstraZeneca, Merck, and Other Key Peers #access #AccessMarket #MarketGrowth #MarketInsights #MarketSegmentation #OncologyDrug #OncologyDrugs #PatientAccess #PharmaceuticalCompanies #PrecisionMedicine #Roche #SoutheastAsia #StrategicInsights